Skip to content
sellWeak cluster of 3

Bryan Ball sold $5,045 of WHWK

See remarks at Whitehawk Therapeutics, Inc.. 2,147 shares at an average of $2.35, traded Mar 3, 2025, filed Mar 4, 2025.

Warning score
15
Value
$5,045
2,147 shares
Holdings after
102,853
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $5k at market
    0
  • Share of holdings sold
    Sold 2.0% of holdings
    0
  • Cluster
    3 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-25-006676, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 1, 2025MOption exercise
Common Stock
+5,000--105,000Mar 4, 2025
Mar 3, 2025SOpen-market sale
Common Stock
-2,147$2.35$5,045102,853Mar 4, 2025
Mar 4, 2025AGrant or award
Common Stock
+100,000$2.40$240k202,853Mar 4, 2025
Mar 1, 2025MOption exercise
Restricted Stock Unitsderivative
-5,000$0.00$015,000Mar 4, 2025

Related signals

Other insiders at Whitehawk Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
0Weak
WHWKsell
Whitehawk Therapeutics, Inc.
Bryan Ball
See remarks
$6,070
1,834 shares
-1%
30Weak
WHWKsell 3
Whitehawk Therapeutics, Inc.
David James Lennon
CHIEF EXECUTIVE OFFICER
$13k
5,690 shares
-15%
27Weak
WHWKsell 3
Whitehawk Therapeutics, Inc.
Scott M. Giacobello
CHIEF FINANCIAL OFFICER
$6,594
2,806 shares
-10%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bryan Ball sold $5,045 of WHWK | InsiderTell